AHA/ASA Journals14d
Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
Medscape29d
‘A Turning Point’ in Heart Failure
For decades, physicians had little to offer patients who have heart failure with preserved ejection fraction (HFpEF), which is a growing global health problem with a grim death rate in the 5 years ...
Nasdaq22d
Tenax Therapeutics Expands Phase 3 LEVEL Program For TNX-103 In PH-HFpEF Treatment
The company has also received FDA approval to initiate LEVEL-2, a global Phase 3 study for TNX-103 in PH-HFpEF, with the first patient expected to be enrolled later this year. This study aims to ...
Medscape3d
How Do Patients With Heart Failure With Preserved Ejection Fraction Die?
Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby allowing ...
ahajournals.org29d
Right Ventricular Stiffening and Anisotropy Alterations in Pulmonary Hypertension: Mechanisms and Relations to Right Heart Failure
Pulmonary hypertension (PH) results in increased right ventricular (RV) afterload, leading to RV dysfunction and failure. The mechanisms underlying maladaptive RV remodeling are poorly understood. In ...
BMJ18d
Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction
Objective The heterogeneous pathophysiology of the diverse heart failure with preserved ejection fraction (HFpEF) phenotypes needs to be examined. We aim to assess differences in the biomarkers among ...
LinkedIn9d
Tanya Ridding’s Post
Director @ Invenia: C-Suite, Board & Executive Search 🔎 | Start-up Mentor | 36,000+ Followers | Medtech, Healthtech & Life Sciences 💫 ...